ExPEC10V
| Vaccine description | |
|---|---|
| Target | Escherichia coli |
| Vaccine type | Conjugate |
| Clinical data | |
| Other names | ExPEC10-V; ExPEC-10V; ExPECV10; ExPEC-V10; VAC-52416; VAC52416; JNJ-69968054; JNJ69968054 |
| Routes of administration | Intramuscular injection |
ExPEC10V, also known as VAC-52416 or JNJ-69968054, is a vaccine against Escherichia coli infection.[1][2] It is an Escherichia coli polysaccharide conjugate vaccine.[1][2] The vaccine is administered by intramuscular injection.[1] It is being developed by Janssen Pharmaceuticals.[1] As of April 2023, ExPEC10V is in phase 3 clinical trials.[1] It is under development towards approval in the United States, Europe, and Japan.[1] The vaccine is a 10-valent form of the earlier ExPEC4V.[2]
See also
References
- ^ a b c d e f "VAC 52416". AdisInsight. 28 April 2023. Retrieved 28 February 2025.
- ^ a b c Doiron RC, Cotechini T, Nickel JC (June 2024). "It's Time to Embrace Vaccination as We Enter the Postantibiotic Era of Recurrent Urinary Tract Infection Management". The Journal of Urology. 211 (6): 797–799. doi:10.1097/JU.0000000000003969. PMID 38704743.
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.